EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases

Zhibo Yang, Ridong Feng, Hai Zhao

Apoptosis · 2024-10 · 29 (9-10) · 1330-1360

DOI: 10.1007/s10495-024-01993-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Apoptosis, online erschienen am 16.07.2024. Verfasst von Zhibo Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, 3201 Hospital of Xi'an Jiaotong University Health Science Center, Hanzhong, 723000, Shaanxi, China. Hauptthemen laut MEDLINE: Copper, Hepatolenticular Degeneration. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 357 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a newly characterized form of regulated cell death driven by copper accumulation, has emerged as a significant mechanism underlying various non-cancerous diseases. This review delves into the complex interplay between copper metabolism and the pathogenesis of conditions such as Wilson's disease (WD), neurodegenerative disorders, and cardiovascular pathologies. We examine the molecular mechanisms by which copper dysregulation induces cuproptosis, highlighting the pivotal roles of key copper transporters and enzymes. Additionally, we evaluate the therapeutic potential of copper chelation strategies, which have shown promise in experimental models by mitigating copper-induced cellular damage and restoring physiological homeostasis. Through a comprehensive synthesis of recent advancements and current knowledge, this review underscores the necessity of further research to translate these findings into clinical applications. The ultimate goal is to harness the therapeutic potential of targeting cuproptosis, thereby improving disease management and patient outcomes in non-cancerous conditions associated with copper dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperHepatolenticular DegenerationHumansAnimalsCell DeathNeurodegenerative DiseasesHomeostasisCardiovascular Diseases

Stichwörter der Autor:innen

BiomarkersCardiovascular diseasesCopper chelation therapyCopper homeostasisCuproptosisNeurodegenerative diseasesTherapeutic interventions

Substanzen

Copper

Autor:innen und Institutionen

  • Department of Neurosurgery, 3201 Hospital of Xi'an Jiaotong University Health Science Center, Hanzhong, 723000, Shaanxi, China.
  • Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), 79 Qingchun Rd., Shangcheng District, Hangzhou, 330100, Zhejiang, China.
  • Department of Neurosurgery, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266005, Shandong, China. yidao@qdu.edu.cn.

Förderung

  • Shandong Province Natural Science Foundation

Zitieren

APA

Yang, Z., Feng, R., & Zhao, H. (2024). Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases. Apoptosis, 29(9-10), 1330-1360. https://doi.org/10.1007/s10495-024-01993-y

Vancouver

Yang Z, Feng R, Zhao H. Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases. Apoptosis. 2024;29(9-10):1330-1360. doi:10.1007/s10495-024-01993-y

BibTeX
@article{Yang2024,
  author = {Yang, Zhibo and Feng, Ridong and Zhao, Hai},
  title = {Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases},
  journal = {Apoptosis},
  year = {2024},
  volume = {29},
  number = {9-10},
  pages = {1330--1360},
  doi = {10.1007/s10495-024-01993-y}
}
Kostenlos starten →